Comparison of clinical features and outcomes between HBV-related and non-B non-C hepatocellular carcinoma

被引:25
|
作者
Xue, Xiulan [1 ]
Liao, Wei [2 ]
Xing, Yugang [3 ]
机构
[1] Xiamen Univ, Affiliated Hosp 1, Dept Infect Dis, Xiamen, Fujian, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Intens Care Unit, Guangzhou, Peoples R China
[3] Kunshan Tradit Chinese Med Hosp, Dept Oncol, Suzhou, Jiangsu, Peoples R China
关键词
Hepatitis B virus; Prognosis; Hepatocellular carcinoma; Biomarker; CHRONIC HEPATITIS-B; COMBINATION THERAPY; PROGNOSTIC-FACTORS; SURGICAL OUTCOMES; VIRUS INFECTION; VIRAL STATUS; MONOTHERAPY; ENTECAVIR; RISK;
D O I
10.1186/s13027-020-0273-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective To evaluate the difference between hepatitis B virus related hepatocellular carcinoma (HBV-HCC) and non-HBV non-HCV hepatocellular carcinoma (NBNC-HCC) patients based on clinical features and prognosis. Methods A total of 175 patients with HCC were enrolled. Patients' characteristics were extracted from medical records. Among them, 107 patients were positive for HBsAg and negative for HCV-Ab while 68 patients were negative for HBsAg and HCV-Ab. Results The patients in the NBNC-HCC group were significantly older than those in the HBV-HCC group (P = 0.045). Moreover, vascular invasion was found in 23.4% of HBV-HCC patients, which was significantly higher than that in the NBNC-HCC patients with 10.3% (P = 0.029). Kaplan-Meier analysis revealed that HBV-HCC patients had significantly worse outcomes in terms of overall survival (P = 0.036). Compared with the NBNC-HCC patients, the HBV-HCC patients had a significantly worse disease-free survival (P = 0.0018). The multivariate analysis results indicated that TNM stage (HR = 1.541, 95%CI 1.072-2.412, P = 0.002) and HBV infection (HR = 1.087, 95%CI 1.012-1.655, P = 0.042) were independent risk variables for overall survival. While vascular invasion (HR = 1.562, 95%CI 1.013-2.815, P = 0.042) and HBV infection (HR = 1.650, 95%CI 1.017-2.676, P = 0.037) were independent risk factors associated with disease-free survival. Conclusion Our data revealed that HBV-HCC is more common in young males with vascular invasion, while NBNC-HCC occurs mostly in elderly patients, and overall survival rate is significantly better than that of HBV-HCC. Our study therefore provides evidence that patients with HBV-HCC require closer follow-up due to their poor prognosis.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Impact of smoking habit on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma
    Keita Kai
    Hiroki Koga
    Shinichi Aishima
    Atsushi Kawaguchi
    Koutaro Yamaji
    Takao Ide
    Junji Ueda
    Hirokazu Noshiro
    [J]. World Journal of Gastroenterology, 2017, (08) : 1397 - 1405
  • [42] Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area
    Lee, Seung Bum
    Kim, Kang Mo
    An, Jihyun
    Lee, Danbi
    Shim, Ju Hyun
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    [J]. LIVER INTERNATIONAL, 2016, 36 (09) : 1351 - 1361
  • [43] Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma
    Shan-Shan Wu
    Quan-Yuan Shan
    Wen-Xuan Xie
    Bin Chen
    Yang Huang
    Yu Guo
    Xiao-Yan Xie
    Ming-De Lu
    Bao-Gang Peng
    Ming Kuang
    Shun-Li Shen
    Wei Wang
    [J]. Clinical and Translational Oncology, 2020, 22 : 401 - 410
  • [44] Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma
    Wu, Shan-Shan
    Shan, Quan-Yuan
    Xie, Wen-Xuan
    Chen, Bin
    Huang, Yang
    Guo, Yu
    Xie, Xiao-Yan
    Lu, Ming-De
    Peng, Bao-Gang
    Kuang, Ming
    Shen, Shun-Li
    Wang, Wei
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (03): : 401 - 410
  • [45] Outcomes After Curative Hepatectomy in Patients with Non-B Non-C Hepatocellular Carcinoma And Hepatitis B Virus Hepatocellular Carcinoma From Non-Cirrhotic Liver
    Kim, Jong Man
    Kwon, Choon Hyuck David
    Joh, Jae-Won
    Park, Jae Berm
    Lee, Joon Hyeok
    Kim, Sung Joo
    Paik, Seung Woon
    Park, Cheol Keun
    Yoo, Byung Chul
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (08) : 976 - 981
  • [46] Which is critical problem, occult HBV infection or mitochondrial DNA mutation in non-B, non-C hepatocellular carcinoma in Japan?.
    Tamori, A
    Nishiguchi, S
    Nishikawa, M
    Kubo, S
    Narimatsu, T
    Koh, N
    Shiomi, S
    Hirohashi, K
    Kinoshita, H
    Inoue, M
    Otani, S
    [J]. HEPATOLOGY, 2001, 34 (04) : 677A - 677A
  • [47] Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection
    Omichi, Kiyohiko
    Shindoh, Junichi
    Yamamoto, Satoshi
    Matsuyama, Yutaka
    Akamatsu, Nobuhisa
    Arita, Junichi
    Kaneko, Junichi
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S1034 - S1040
  • [48] Molecular characteristics of non-cancerous liver tissue in non-B non-C hepatocellular carcinoma
    Utsunomiya, Tohru
    Shimada, Mitsuo
    [J]. HEPATOLOGY RESEARCH, 2011, 41 (08) : 711 - 721
  • [49] Outcomes of Non-B Non-C Hepatocellular Carcinoma with Reference to Patients with Interferon-Induced Hepatitis C Virus Eradication
    Hiroji Shinkawa
    Shogo Tanaka
    Shigekazu Takemura
    Tokuji Ito
    Takanori Aota
    Toru Miyazaki
    Shoji Kubo
    [J]. Journal of Gastrointestinal Surgery, 2020, 24 : 1809 - 1817
  • [50] Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study
    Kurokawa, Y
    Matoba, R
    Takemasa, I
    Nakamori, S
    Tsujie, M
    Nagano, H
    Dono, K
    Umeshita, K
    Sakon, M
    Ueno, N
    Kita, H
    Oba, S
    Ishii, S
    Kato, K
    Monden, M
    [J]. JOURNAL OF HEPATOLOGY, 2003, 39 (06) : 1004 - 1012